Biblio

Export 8 results:
Author Title Type [ Year(Asc)]
Filters: Author is Wimo, Anders  [Clear All Filters]
2025
A. Wimo, Handels, R., Blennow, K., K Kirsebom, B. - E., Selnes, P., Bon, J., Emersic, A., Gonzalez-Ortiz, F., Kramberger, M. Gregoric, Sköldunger, A., Speh, A., Timón-Reina, S., Vromen, E., Visser, P. Jelle, Winblad, B., and Fladby, T., “Cost-effectiveness of diagnosing and treating patients with early Alzheimer's disease with anti-amyloid treatment in a clinical setting.”, J Alzheimers Dis, p. 13872877251323231, 2025.
2021
A. Wimo, Belger, M., Bon, J., Jessen, F., Dumas, A., Kramberger, M. G., Jamilis, L., Johansson, G., Salas, A. Rodrigo, Gómez, O. Rodríguez, Sannemann, L., Stoekenbroek, M., Telleria, M. Gurruchaga, Valero, S., Vermunt, L., Waterink, L., Winblad, B., Visser, P. Jelle, Zwan, M., and Boada, M., “A Cost-Consequence Analysis of Different Screening Procedures in Alzheimer's Disease: Results from the MOPEAD Project.”, J Alzheimers Dis, vol. 83, no. 3, pp. 1149-1159, 2021.
2018
A. Wimo, “The End of the Beginning of the Alzheimer's Disease Nightmare: A Devil's Advocate's View.”, J Alzheimers Dis, 2018.
N. Janssen, Handels, R. L., Sköldunger, A., Woods, B., Jelley, H., Edwards, R. Tudor, Orrell, M., Selbæk, G., Røsvik, J., Gonçalves-Pereira, M., Marques, M. J., Zanetti, O., Portolani, E., Irving, K., Hopper, L., Meyer, G., Bieber, A., Stephan, A., Kerpershoek, L., Wolfs, C. A. G., de Vugt, M. E., Verhey, F. R. J., and Wimo, A., “Impact of Untimely Access to Formal Care on Costs and Quality of Life in Community Dwelling People with Dementia.”, J Alzheimers Dis, vol. 66, no. 3, pp. 1165-1174, 2018.
R. L. H. Handels, Sköldunger, A., Bieber, A., Edwards, R. Tudor, Gonçalves-Pereira, M., Hopper, L., Irving, K., Jelley, H., Kerpershoek, L., Marques, M. J., Meyer, G., Michelet, M., Portolani, E., Røsvik, J., Selbaek, G., Stephan, A., de Vugt, M., Wolfs, C., Woods, B., Zanetti, O., Verhey, F., and Wimo, A., “Quality of Life, Care Resource Use, and Costs of Dementia in 8 European Countries in a Cross-Sectional Cohort of the Actifcare Study.”, J Alzheimers Dis, vol. 66, no. 3, pp. 1027-1040, 2018.
2017
R. L. H. Handels, Wimo, A., Dodel, R., Kramberger, M. G., Visser, P. Jelle, Molinuevo, J. Luis, Verhey, F. R. J., and Winblad, B., “Cost-Utility of Using Alzheimer's Disease Biomarkers in Cerebrospinal Fluid to Predict Progression from Mild Cognitive Impairment to Dementia.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1477-1487, 2017.
C. Reed, Happich, M., Argimon, J. Maria, Haro, J. Maria, Wimo, A., Bruno, G., Dodel, R., Jones, R. W., Vellas, B., and Belger, M., “What Drives Country Differences in Cost of Alzheimer's Disease? An Explanation from Resource Use in the GERAS Study.”, J Alzheimers Dis, vol. 57, no. 3, pp. 797-812, 2017.
2016
A. Wimo, Sjölund, B. - M., Sköldunger, A., Qiu, C., Klarin, I., Nordberg, G., and von Strauss, E., “Cohort Effects in the Prevalence and Survival of People with Dementia in a Rural Area in Northern Sweden.”, J Alzheimers Dis, vol. 50, no. 2, pp. 387-96, 2016.